BBNXBeta Bionics, Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $100M
- 54% YoY
- Operating margin
- -71.5%
- 2.9% YoY
- EBITDA
- −$70M
- 59% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired16% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $12M | $65M | $100M | 54% |
| Operating income | −$36M | −$45M | −$72M | 58% |
| Net income | −$44M | −$55M | −$73M | 34% |
| Operating cash flow | −$32M | −$48M | −$51M | 5.5% |
| Capex | $402K | $3M | $5M | 56% |
| Stock-based comp | $6M | $6M | $16M | 157% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $2M · 15
- Net
- −$2M
Pay vs performance
No pay-versus-performance disclosure yet.